Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM168A antisense RNA 1 (FAM168A-AS1) is a human long non-coding RNA gene located antisense to the FAM168A gene. As an antisense RNA, it is classified as a non-coding RNA that does not encode a protein. Although many antisense lncRNAs are known to regulate the expression of their corresponding sense genes through diverse mechanisms—including mRNA stabilization, chromatin modification, or acting as competing endogenous RNAs—there is currently no direct functional or disease-related information available for FAM168A-AS1 in the referenced genetic and biomedical databases[4][6][11]. Therefore, at present, it is not considered a therapeutic target, receptor, enzyme, transporter, or similar druggable entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FAM168A antisense RNA 1 (FAM168A-AS1).